Patients with cirrhosis at increased risk of death from COVID-19, study finds
An international study led by researchers at Oxford University Hospitals NHS Foundation Trust has shown that patients with cirrhosis are at increased risk of dying as a result of COVID-19. Oxford, October…
Calling transplant centres to share how they are affected by COVID-19
19 September 2020 EASL is part of a joint initiative on the impact of COVID-19 on liver transplantation, aiming to explore how patients, healthcare professionals, and liver transplant centres across the world…
Global Week for Action on NCDs: We need more accountability
This week, 7-13 September, marks the 2020 Global Week for Action on NCDs (non-communicable diseases). The campaign draws on energy, inspiration, determination, optimism, and outrage to focus efforts on ensuring NCD prevention…
A pioneer in transplantation: a tribute to Prof. Chris Gips (17 February 1932 – 29 July 2020)
It is with great sadness that EASL announces the passing of Prof. Christiaan Hendrik (Chris) Gips, a pioneer in liver transplantation, patient empowerment, and education in the field of hepatology. His work…
Past and Present: Tall oaks from little acorns grow
EASL’s Digital ILC 2020 was the 55th iteration of a flagship annual congress – a firmly rooted and longstanding tradition that evolved into a sparkling virtual event. Over half a century has…
On the go? Here’s the Saturday recap.
On this final day of the Digital ILC 2020, the Daily News features the Nurses and AHP Forum, the late breaking oral abstract presentations, and the latest on precision medicine in the…
EASL policy statement on drug use and the global hepatitis C elimination goal
At Digital ILC 2020, EASL is launching a policy paper with its accompanying lay summary about drug use and the global hepatitis C elimination goal. WHO has set a goal of eliminating…